Jun 21, 2021 7:00 am EDT Castle Biosciences is Listed in the Houston Chronicle’s “CHRON 100” as One of the 100 Most Successful Publicly Traded Companies in Houston
May 24, 2021 7:00 am EDT Castle Biosciences to Host Ribbon Cutting Ceremony at New Corporate Headquarters
May 21, 2021 7:00 am EDT Castle Biosciences Supports the American Skin Association with Research Grant
May 20, 2021 7:00 am EDT Expert Panel Provides Framework for Incorporating DecisionDx-SCC Results Into Clinical Decision Making for Cutaneous Squamous Cell Carcinoma Patients With One or More Risk Factors
May 19, 2021 7:00 am EDT Castle Biosciences to Participate in the Oppenheimer MedTech, Tools, & Diagnostics Summit
May 11, 2021 7:00 am EDT Tiffany Olson, Seasoned Diagnostics Executive, Joins Castle Biosciences’ Board of Directors
